Poster 57
- Kelley Tangredi
- May 9, 2023
- 1 min read
Updated: Jul 8, 2023
Real-World Effectiveness and Safety in a Phase 4 Study of Tildrakizumab in Patients with Moderate-to-Severe Plaque Psoriasis
Authors: Neal Bhatia, J Gabriel Vasquez, Brad Schenkel, Ranga Gogineni, Jayme Heim
Comments